Genomenon

About:

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.

Twitter/X: Genomenon

Top Investors: National Institutes of Health, University of Michigan, Invest Detroit, Beringea, Michigan Rise

Description:

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. It was founded in 2014 and is headquartered in Ann Arbor, Michigan.

Total Funding Amount:

$38.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2014-01-01

Contact Email:

hello(AT)genomenon.com

Founders:

Mark J. Kiel, Megan S. Lim, Steve Schwartz

Number of Employees:

11-50

Last Funding Date:

2024-05-16

IPO Status:

Private

Industries: